|
|
Volumn 484, Issue 7393, 2012, Pages 149-150
|
|
China's stem-cell rules go unheeded
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL ORGANELLE;
DISEASE PREVALENCE;
DISEASE TREATMENT;
DRUG;
ENZYME ACTIVITY;
EPIDEMIOLOGY;
GENE EXPRESSION;
GENOMICS;
STATE ROLE;
ADIPOSE DERIVED STEM CELL;
ADVERTIZING;
ALZHEIMER DISEASE;
AUTISM;
CHINA;
CORD BLOOD STEM CELL TRANSPLANTATION;
DIABETES MELLITUS;
GOVERNMENT REGULATION;
HEALTH CARE COST;
HUMAN;
LAW ENFORCEMENT;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SHORT SURVEY;
STEM CELL RESEARCH;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
AUTISTIC DISORDER;
CHINA;
CONTROLLED CLINICAL TRIALS AS TOPIC;
HUMANS;
PARKINSON DISEASE;
PATIENT ADVOCACY;
REPRODUCIBILITY OF RESULTS;
STEM CELL TRANSPLANTATION;
CHINA;
|
|
EID: 84859612307
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/484149a Document Type: Short Survey |
|
Times cited : (39)
|
|
References (0)
|
